NIVF
NIVF
NASDAQ · Health Care

Newgenivf Group Ltd-A

$0.97
-0.08 (-7.54%)
As of May 16, 2:37 AM ET ·
Financial Highlights (FY 2026)
Revenue
9.92M
Net Income
20.75M
Gross Margin
20.2%
Profit Margin
209.0%
Rev Growth
D/E Ratio
0.16
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 20.2% 63.4% 63.4% 63.4%
Operating Margin 231.2% 15.0% 13.3% 13.3%
Profit Margin 209.0% 10.4% 12.9% 12.1%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 9.92M 401.7K 362.7K 344.3K
Gross Profit 2.01M 254.9K 230.1K 218.5K
Operating Income 22.95M 60.1K 48.3K 45.7K
Net Income 20.75M 41.8K 46.7K 41.5K
Gross Margin 20.2% 63.4% 63.4% 63.4%
Operating Margin 231.2% 15.0% 13.3% 13.3%
Profit Margin 209.0% 10.4% 12.9% 12.1%
Rev Growth +17.6% -6.2% -6.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 38.8K 153.4K 184.7K 169.1K
Total Equity 237.3K 435.1K 422.0K 475.1K
D/E Ratio 0.16 0.35 0.44 0.36
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 21.15M 62.8K 66.4K 61.5K
Free Cash Flow 54.6K 52.4K 38.3K